You are here: Industry Insights > Precision Oncology

News List

Veraxa Biotech and Indivumed to Jointly Develop Precision Oncology Antibody Drugs contractpharma
August 11, 2021
Veraxa Biotech GmbH and Indivumed GmbH have entered an agreement to jointly discover modulatory and functional antibodies against several targets that are relevant for colorectal cancer.
VERAXA Biotech and Indivumed Cooperate on the Development of Precision Oncology Antibody Drugs b3cnewswire
August 11, 2021
VERAXA Biotech GmbH, Heidelberg, and Indivumed GmbH, Hamburg, announced today their agreement to jointly discover modulatory and functional antibodies against several targets that are relevant for colorectal cancer.
AVATAMED sets up Joint Service Lab with A*STAR's Institute of Molecular and Cell Biology to offer Precision Oncology Services prnasia
June 01, 2021
AVATAMED, a precision medicine service company based in Singapore, announced the setting up of a joint lab with Singapore's Institute of Molecular and Cell Biology (IMCB) at the Agency for Science, Technology and Research (A*STAR), to offer precision ...
Bayer gets EU CHMP nod for precision oncology treatment larotrectinib biospectrumasia
August 04, 2019
Upon approval, larotrectinib would be the first therapy in Europe with a tumor-agnostic indication
Concerto HealthAI collaborates with Pfizer for precision oncology biospectrumasia
April 11, 2019
A Concerto HealthAI-Pfizer joint steering committee will oversee the collaboration. The first outcomes research and publications are expected in early 2020.